TECOS VISITA 202324

TECOS was an event-driven study designed to assess the long-term CV safety of the addition of sitagliptin to usual care, compared to usual care

management About the TECOS CV Safety Trial TECOS was an event-driven trial conducted in adults with type 2 diabetes and a history of

tecos TECOS is a randomized, double-blind, controlled trial comparing sitagliptin and placebo when added to best usual care in patients with T2DM and cardiovascular

tecos Balbino Fuenmayor y Juan Perez también se encargaron de producir una cada uno ante Junior Guerra Para la sexta entrada, Tecos se